Milene T. Saavedra

1.9k total citations
41 papers, 1.4k citations indexed

About

Milene T. Saavedra is a scholar working on Pulmonary and Respiratory Medicine, Epidemiology and Molecular Biology. According to data from OpenAlex, Milene T. Saavedra has authored 41 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Pulmonary and Respiratory Medicine, 13 papers in Epidemiology and 10 papers in Molecular Biology. Recurrent topics in Milene T. Saavedra's work include Cystic Fibrosis Research Advances (28 papers), Neonatal Respiratory Health Research (7 papers) and Bacterial biofilms and quorum sensing (6 papers). Milene T. Saavedra is often cited by papers focused on Cystic Fibrosis Research Advances (28 papers), Neonatal Respiratory Health Research (7 papers) and Bacterial biofilms and quorum sensing (6 papers). Milene T. Saavedra collaborates with scholars based in United States, Canada and France. Milene T. Saavedra's co-authors include Jerry A. Nick, Kenneth C. Malcolm, Jennifer L. Taylor‐Cousar, David P. Nichols, Katie R. Poch, Silvia M. Caceres, Michael L. Vasil, Samuel M. Moskowitz, Scott H. Randell and Michael B. Fessler and has published in prestigious journals such as The Journal of Immunology, PLoS ONE and American Journal of Respiratory and Critical Care Medicine.

In The Last Decade

Milene T. Saavedra

39 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Milene T. Saavedra United States 20 686 425 305 273 150 41 1.4k
Katie R. Poch United States 18 377 0.5× 453 1.1× 486 1.6× 326 1.2× 133 0.9× 37 1.3k
Delphyne Descamps France 20 290 0.4× 444 1.0× 299 1.0× 340 1.2× 237 1.6× 49 1.2k
Ashley Keller United States 16 347 0.5× 542 1.3× 331 1.1× 204 0.7× 267 1.8× 29 1.4k
Riny Janssen Netherlands 22 357 0.5× 292 0.7× 531 1.7× 652 2.4× 460 3.1× 47 1.7k
Margaret Dunkley Australia 24 376 0.5× 297 0.7× 747 2.4× 409 1.5× 205 1.4× 54 1.7k
Marina Ulanova Canada 23 182 0.3× 402 0.9× 614 2.0× 747 2.7× 118 0.8× 90 1.8k
Jeroen D. Langereis Netherlands 23 157 0.2× 352 0.8× 634 2.1× 516 1.9× 109 0.7× 74 1.5k
Vivekananda Datta United States 15 269 0.4× 350 0.8× 246 0.8× 159 0.6× 530 3.5× 21 1.5k
Jean‐San Chia Taiwan 29 129 0.2× 481 1.1× 332 1.1× 516 1.9× 221 1.5× 75 1.9k
Emily Gwyer Findlay United Kingdom 21 198 0.3× 368 0.9× 1.0k 3.3× 333 1.2× 184 1.2× 32 1.8k

Countries citing papers authored by Milene T. Saavedra

Since Specialization
Citations

This map shows the geographic impact of Milene T. Saavedra's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Milene T. Saavedra with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Milene T. Saavedra more than expected).

Fields of papers citing papers by Milene T. Saavedra

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Milene T. Saavedra. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Milene T. Saavedra. The network helps show where Milene T. Saavedra may publish in the future.

Co-authorship network of co-authors of Milene T. Saavedra

This figure shows the co-authorship network connecting the top 25 collaborators of Milene T. Saavedra. A scholar is included among the top collaborators of Milene T. Saavedra based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Milene T. Saavedra. Milene T. Saavedra is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Everhart, Robin S., et al.. (2025). Mental health and adherence in CF: Self-efficacy and perceived barriers as mediators. Journal of Cystic Fibrosis. 24(2). 334–340. 1 indexed citations
2.
Kapnadak, Siddhartha G., Oliver J. McElvaney, Jordan Dunitz, et al.. (2024). Attitudes toward and preparedness for lung transplantation among individuals with cystic fibrosis in the era of highly effective modulators. BMC Pulmonary Medicine. 24(1). 348–348. 2 indexed citations
4.
Caceres, Silvia M., Linda Sanders, Katie R. Poch, et al.. (2022). Blood mRNA biomarkers distinguish variable systemic and sputum inflammation at treatment initiation of inhaled antibiotics in cystic fibrosis: A prospective non-randomized trial. PLoS ONE. 17(5). e0267592–e0267592. 1 indexed citations
5.
Beswick, Daniel M. & Milene T. Saavedra. (2020). Stakeholder feedback informs investigations for chronic rhinosinusitis in cystic fibrosis. International Forum of Allergy & Rhinology. 11(1). 79–80. 2 indexed citations
6.
De, Prithwiraj, Anita G. Amin, Barbara Graham, et al.. (2020). Urine lipoarabinomannan as a marker for low-risk of NTM infection in the CF airway. Journal of Cystic Fibrosis. 19(5). 801–807. 12 indexed citations
7.
Somayaji, Ranjani, Jonathan D. Cogen, Christopher H. Goss, et al.. (2019). Oral Azithromycin Use and the Recovery of Lung Function from Pulmonary Exacerbations Treated with Intravenous Tobramycin or Colistimethate in Adults with Cystic Fibrosis. Annals of the American Thoracic Society. 16(7). 853–860. 9 indexed citations
8.
Saavedra, Milene T., Bradley S. Quon, Anna Faino, et al.. (2018). Whole Blood Gene Expression Profiling Predicts Severe Morbidity and Mortality in Cystic Fibrosis: A 5-Year Follow-Up Study. Annals of the American Thoracic Society. 15(5). 589–598. 5 indexed citations
9.
Nick, Jerry A., Silvia M. Caceres, Katie R. Poch, et al.. (2016). Extremes of Interferon-Stimulated Gene Expression Associate with Worse Outcomes in the Acute Respiratory Distress Syndrome. PLoS ONE. 11(9). e0162490–e0162490. 21 indexed citations
10.
Taylor‐Cousar, Jennifer L., Alexandra Wilson, Marci K. Sontag, et al.. (2016). Glucose >200 mg/dL during Continuous Glucose Monitoring Identifies Adult Patients at Risk for Development of Cystic Fibrosis Related Diabetes. Journal of Diabetes Research. 2016. 1–8. 25 indexed citations
11.
Sagel, Scott D., Valeria Thompson, James F. Chmiel, et al.. (2015). Effect of Treatment of Cystic Fibrosis Pulmonary Exacerbations on Systemic Inflammation. Annals of the American Thoracic Society. 12(5). 708–717. 48 indexed citations
12.
Nick, Jerry A., Anne E. Getz, Henry P. Barham, et al.. (2014). Comparison of radiographic and clinical characteristics of low‐risk and high‐risk cystic fibrosis genotypes. International Forum of Allergy & Rhinology. 4(11). 915–920. 20 indexed citations
13.
Nick, Jerry A., Linda Sanders, Brian Ickes, et al.. (2013). Blood mRNA biomarkers for detection of treatment response in acute pulmonary exacerbations of cystic fibrosis. Thorax. 68(10). 929–937. 20 indexed citations
14.
Malcolm, Kenneth C., Silvia M. Caceres, Stacey L. Martiniano, et al.. (2013). Mycobacterium abscessus Induces a Limited Pattern of Neutrophil Activation That Promotes Pathogen Survival. PLoS ONE. 8(2). e57402–e57402. 57 indexed citations
15.
Nick, Jerry A., Robert L. Young, David P. Nichols, et al.. (2010). Effects of Gender and Age at Diagnosis on Disease Progression in Long-term Survivors of Cystic Fibrosis. American Journal of Respiratory and Critical Care Medicine. 182(5). 614–626. 86 indexed citations
16.
Saavedra, Milene T., Grant Hughes, Linda Sanders, et al.. (2008). Circulating RNA Transcripts Identify Therapeutic Response in Cystic Fibrosis Lung Disease. American Journal of Respiratory and Critical Care Medicine. 178(9). 929–938. 15 indexed citations
17.
Nold, Marcel F., Claudia A. Nold‐Petry, Gregory B. Pott, et al.. (2008). Endogenous IL-32 Controls Cytokine and HIV-1 Production. The Journal of Immunology. 181(1). 557–565. 106 indexed citations
18.
Saavedra, Milene T., James West, Scott H. Randell, et al.. (2008). Abrogation of Anti-Inflammatory Transcription Factor LKLF in Neutrophil-Dominated Airways. American Journal of Respiratory Cell and Molecular Biology. 38(6). 679–688. 15 indexed citations
19.
Walker, Travis S., Kerry Tomlin, G. Scott Worthen, et al.. (2005). Enhanced Pseudomonas aeruginosa Biofilm Development Mediated by Human Neutrophils. Infection and Immunity. 73(6). 3693–3701. 206 indexed citations
20.
Rodman, David M., Sonya L. Heltshe, Marci K. Sontag, et al.. (2005). Late Diagnosis Defines a Unique Population of Long-term Survivors of Cystic Fibrosis. American Journal of Respiratory and Critical Care Medicine. 171(6). 621–626. 119 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026